Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Nuclear Receptors and Signaling, and Genetic Neurodegenerative Diseases.
Defining the molecular identity and morphology of glia limitans superficialis astrocytes in vertebrates
Toward a biological definition of neuronal and glial synucleinopathies
Aerobic exercise-induced changes in fluid biomarkers in Parkinson’s disease
Faster reaction times of CSF Alpha-Synuclein Seed Amplification Assay predict the Diffuse Malignant subtype of Parkinson’s Disease at 10-year follow-up
Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis
Learning critically drives parkinsonian motor deficits through imbalanced striatal pathway recruitment
Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson’s disease and multiple system atrophy
Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial
Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson’s disease phenotypes
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy
Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression
Discussion of Research Priorities for Gait Disorders in Parkinson's Disease
COVID-19 Vaccination for Persons with Parkinson’s Disease: Light at the End of the Tunnel?
Impact of the <scp>COVID</scp>‐19 Pandemic on Parkinson's Disease and Movement Disorders
Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice
A rapid α‐synuclein seed assay of Parkinson’s disease CSF panel shows high diagnostic accuracy
Alterations in the intrinsic properties of striatal cholinergic interneurons after dopamine lesion and chronic L-DOPA
Impact of the <scp>COVID</scp>‐19 Pandemic on Parkinson's Disease and Movement Disorders
Motor phenotype classification in moderate to advanced PD in BioFIND study
Mitochondrial dysfunction and mitophagy defect triggered by heterozygous <i>GBA</i> mutations
Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD
Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center
Enhanced histamine H2 excitation of striatal cholinergic interneurons in l-DOPA-induced dyskinesia
Striatal cholinergic interneuron regulation and circuit effects
Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD